HU professor wins over 3m. euro grant for groundbreaking cancer research

Three Hebrew U. researchers win a total of over 7m. euros from the European Research Council for "ground breaking and high risk projects" including the treatment of adult leukemia.

Prof. Reuven Or, from the Bone Marrow Transplantation and Cancer Immunotherapy Research Center, speaks with Pluristem CEO Zami Aberman last month.

Prof. Reuven Or, from the Bone Marrow Transplantation and Cancer Immunotherapy Research Center, speaks with Pluristem CEO Zami Aberman last month.

(photo credit: PLURISTEM)

APRIL 2, 2020 13:35